Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in mice
- 18 December 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (2) , 259-261
Abstract
The endothelium controls blood flow and pressure by releasing several vasoactive factors, among them the vasodilator nitric oxide (NO) and the potent vasoconstrictor endothelin‐1 (ET‐1). Although increased NO levels have been found in excessive erythrocytosis, little is known concerning ET‐1 expression in this condition. Thus, we examined the endothelin system in transgenic mice that due to constitutive overexpression of erythropoietin (Epo) reached hematocrit levels of ~80%. Surprisingly, despite generalized vasodilatation, polycythemic mice exhibited a two‐ to fivefold elevation in ET‐1 mRNA levels in aorta, liver, heart, and kidney. In line with this, increased expression of ET‐1 protein was detected in the pulmonary artery by immunohistochemical analysis. Compared with their wild‐type littermates, aortic rings of Epo transgenic animals exhibited a marked reduction in vascular reactivity to ET‐1 and big ET‐1, but this effect was abrogated upon preincubation with the NO synthase inhibitor N ‐nitro‐ l ‐arginine methyl ester (L‐NAME). Pretreatment of polycythemic mice with the ET A receptor antagonist darusentan for 3 wk significantly prolonged their survival upon acute exposure to L‐NAME. Taken together, these results demonstrate for the first time that excessive erythrocytosis induces a marked activation of the tissue endothelin system that results in increased mortality upon blockade of NO‐mediated vasodilatation. Because ETA antagonism prolonged survival after acute blockade of NO synthesis, endothelin may be regarded as a contributor to the adverse cardiovascular effects of erythrocytosis and may thus represent a new target in the treatment of cardiovascular disease associated with erythrocytosis.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Deutsche Forschungsgemeinschaft (1665/2–2)
- Deutscher Akademischer Austauschdienst
This publication has 39 references indexed in Scilit:
- ET A Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive HypertensionHypertension, 1998
- Increased Activation of Sympathetic Nervous System and Endothelin by Mental Stress in Normotensive Offspring of Hypertensive ParentsCirculation, 1996
- Contribution of endogenous generation of endothelin-1 to basal vascular toneThe Lancet, 1994
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989
- A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channelsJournal Of Hypertension, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences, 1987
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylationNature, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980